Drug Development
AstraZeneca Executes Option Agreement for Cancer Technology
Published in Gene Therapy Weekly, January 27th, 2000
Over the next nine months AstraZeneca will evaluate a version of Vion's TAPET (Tumor Amplified Protein Expression Therapy) bacterial vector, armed with EPTTCO's prodrug activation technology, which uses enzymes to convert inactive prodrugs into cytotoxic anti-cancer agents.
Under the terms of the agreement, Vion and EPTTCO will co-develop these specific EPTTCO-armed TAPET vectors and test them in preclinical cancer models....
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2000-01-27)
More Articles from Gene Therapy Weekly
- Cancer Vaccines
Cytokine Gene Transfer Attacks Melanoma Cells - Gene Transfer (HIV-1)
Glycoprotein Incorporation Into Retroviral Particles Explored - Cancer Immunotherapy
Autologous Vaccine Is Therapeutic In Tumor Model - Clinical Gene Therapy
Bone Marrow Cells are Good Targets for Gene Transfer - HIV-1 (Pathogenesis)
HIV-1-TAT Transfected Cells to Undergo Apoptosis - Infectious Disease Immunotherapy
IL-12 Coadministration Enhances Antigen Vaccine Efficacy - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
